GTC
AVDL
Ghost Tree Capital’s Avadel Pharmaceuticals AVDL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-825,000
| Closed | -$4.16M | – | 46 |
|
|
2020
Q3 | $4.16M | Hold |
825,000
| – | – | 1.2% | 26 |
|
|
2020
Q2 | $6.67M | Buy |
825,000
+475,000
| +136% | +$3.84M | 1.76% | 19 |
|
|
2020
Q1 | $2.78M | Buy |
+350,000
| New | +$2.78M | 0.74% | 25 |
|
|
2018
Q4 | – | Sell |
-450,000
| Closed | -$1.98M | – | 40 |
|
|
2018
Q3 | $1.98M | Hold |
450,000
| – | – | 0.42% | 40 |
|
|
2018
Q2 | $2.76M | Sell |
450,000
-400,000
| -47% | -$2.45M | 0.81% | 35 |
|
|
2018
Q1 | $6.2M | Buy |
+850,000
| New | +$6.2M | 1.25% | 24 |
|
|
2017
Q1 | – | Sell |
-575,000
| Closed | -$5.97M | – | 60 |
|
|
2016
Q4 | $5.97M | Hold |
575,000
| – | – | 1.44% | 24 |
|
|
2016
Q3 | $7.13M | Buy |
575,000
+225,000
| +64% | +$2.79M | 1.16% | 18 |
|
|
2016
Q2 | $3.76M | Buy |
+350,000
| New | +$3.76M | 1.09% | 28 |
|
|
2015
Q4 | – | Sell |
-350,000
| Closed | -$5.71M | – | 49 |
|
|
2015
Q3 | $5.71M | Sell |
350,000
-225,000
| -39% | -$3.67M | 2.57% | 10 |
|
|
2015
Q2 | $12.2M | Buy |
575,000
+375,000
| +188% | +$7.95M | 3.95% | 2 |
|
|
2015
Q1 | $3.6M | Sell |
200,000
-125,000
| -38% | -$2.25M | 1.29% | 34 |
|
|
2014
Q4 | $5.57M | Buy |
+325,000
| New | +$5.57M | 2.67% | 6 |
|
|
2014
Q3 | – | Sell |
-75,000
| Closed | -$1.13M | – | 64 |
|
|
2014
Q2 | $1.13M | Sell |
75,000
-225,000
| -75% | -$3.38M | 0.79% | 32 |
|
|
2014
Q1 | $4.02M | Buy |
300,000
+180,000
| +150% | +$2.41M | 2.39% | 3 |
|
|
2013
Q4 | $966K | Buy |
+120,000
| New | +$966K | 0.59% | 40 |
|